Uniqure NV

$80$125

uniQure N.V. delivers gene therapy with single treatments for curative results. The Company develops a modular platform to bring new disease modifying therapies to patients with severe genetic diseases, as well as offers ongoing clinical programs in hemophilia B and pre-clinical proof-of-concept in Huntington’s disease. The company is delivering on the promise of gene therapy single treatments with potentially curative results. They are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases

Report ID:

UMHE21224

Published:

Jan-2022

Pages:

13

Industry:

HeadQuatered Country:

Netherlands

Geography:

,

Clear
  Get a Free Sample
SKU: UMHE21224 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Value, Product Portfolio, and Business Headquarter
Information on its recent developments including collaborations, and expansions among others
Biography of top management”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1.    Key Facts of the Company
2.    Company Mission
3.    Company Vision
4.    Growth Strategy
5.    Key Products & Services Offered
6.    Infographic
7.    Company Timeline
8.    Executive Team
9.    SWOT Analysis
10.    Key Financials
11. Recent Developments
11.1 Product Launches
11.2 Partnerships”

Companies Mentioned

“Renova Therapeutics
Spark Therapeutics
Prevail Therapeutics
bluebird bio”